Loading...
Market
Will Sun Pharma receive FDA approval for Fibromun by end of Q2 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements and Sun Pharma press releases
Story
Sun Pharma and Philogen Sign Exclusive Deal to Commercialize Anti-Cancer Drug Fibromun
Oct 1, 2024, 08:52 AM
Sun Pharma has entered into an exclusive global commercialization, licensing, and supply agreement with Swiss-Italian company Philogen to commercialize Fibromun, a specialty cancer anti-cancer immunotherapy drug. This partnership aims to leverage Sun Pharma's extensive market reach to bring Fibromun to a broader range of patients worldwide.
View original story
Similar markets
Approval • 33%
Rejection • 33%
Request for more data • 34%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
